|
Association between type 2 diabetes mellitus (T2DM), diabetic therapies and clinical outcomes in patients (pts) with metastatic colorectal cancer (mCRC). |
|
|
Research Funding - Roche Pharma AG (Inst) |
|
|
No Relationships to Disclose |
|
|
Research Funding - Roche Pharma AG (Inst) |
|
|
Research Funding - Roche Pharma AG (Inst) |
|
|
Research Funding - Roche Pharma AG (Inst) |
|
|
Research Funding - Roche Pharma AG (Inst) |
|
|
Research Funding - Roche Pharma AG (Inst) |
|
|
Research Funding - Roche Pharma AG (Inst) |
|
|
Research Funding - Roche Pharma AG (Inst) |
|
|
Research Funding - Roche Pharma AG (Inst) |
|
|
Research Funding - Roche Pharma AG (Inst) |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - roche |
|
|
Research Funding - Roche Pharma AG (Inst) |
|
|
Research Funding - Roche Pharma AG (Inst) |
|
|
Research Funding - Roche Pharma AG (Inst) |
|
|
Research Funding - Roche Pharma AG (Inst) |
|
|
Honoraria - Alchemia; Amgen; Bayer; Merck; Roche; Sirtex Medical |
Research Funding - Pfizer (Inst); Roche (Inst) |